Award
NIH Reporter #4R01AG079890-02
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
Recipient
Oregon Health & Science University
Award Amount
$778,200.00
Ceiling
$778,200.00
Awarded
September 15, 2026
Identifier
4R01AG079890-02
Award for research on GPR39 as a therapeutic target for aging-related vascular cognitive impairment and dementia, funded by the National Institute on Aging for fiscal year 2026.
Description
The project involves developing a small molecule drug targeting GPR39 for aging-related dementia. The award is part of NIH PAR-22-031. The project is highly significant, translational, and innovative, including high-throughput screening, preclinical testing, and lead optimization. Funding is for fiscal year 2026.